MDGL earnings date and history (2026)
Madrigal Pharmaceuticals Inc. (MDGL) next reports earnings on Tue Nov 3. Analysts expect EPS of $1.00 (6 estimates), against -$5.08 in the same quarter a year ago. Last time, on Thu Jul 30, it reported -$1.99 against a -$2.55 consensus (+22.0%). Not investment advice.
See every company reporting on the earnings calendar or the filed financial statements.
Past reports#
Newest first. The surprise is the reported EPS against the consensus going in, in percent; the move is the stock’s close-to-close change over the first session that could trade on the report, shown once that session has settled and only where the report’s session is known.
| Date | Est | Actual | Move |
|---|---|---|---|
| Jul 30, 2026 | -$2.55 | -$1.99 | — |
| May 6, 2026 | -$3.61 | -$3.25 | — |
| Feb 19, 2026 | $0.04 | -$2.57 | — |
| Nov 4, 2025 | -$1.98 | -$5.08 | — |
About this data
Report dates, sessions, consensus EPS estimates, reported EPS and surprises come from Nasdaq's public earnings calendar and analyst pages, read daily; they are estimates, subject to change, and may not be accurate. A quarter the calendar saw is shown with its session; a quarter known only from the analyst page has none, and its move is left blank rather than guessed, because a pre-open and an after-close report trade on different sessions. The move is ChartRow's own: the first settled close that could trade on the report over the close before it, price return. Not investment advice.
FAQ#
- When does MDGL report earnings?
- MDGL is scheduled to report on Tue Nov 3, according to Nasdaq's earnings calendar. Dates are set by the company and can move.
- What EPS is expected from MDGL?
- The consensus estimate is $1.00 a share across 6 analysts; the same quarter a year ago came in at -$5.08.
- Did MDGL beat earnings last quarter?
- Yes: on Thu Jul 30 MDGL reported -$1.99 against a -$2.55 consensus, a +22.0% surprise.